The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, such as the liver, lungs, and spleen. Nevertheless, Ali and Townsend note ...

Avient Corporation ( NYSE: AVNT) Q2 2025 Earnings Conference Call August 1, 2025 8:00 AM ET Ashish K. Khandpur - President, CEO & Chairman of the Board Giuseppe Di Salvo - VP of Investor Relations & ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid arthritis (RA) in patients who have not responded to — or cannot tolerate — ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...